Cristina Csimma
Directeur/Membre du Conseil chez SYNCONA LIMITED
Fortune : - $ au 31/07/2023
Provenance du réseau au premier degré de Cristina Csimma
Entité | Type d'entité | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 32 | |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA.
26
| Subsidiary | Pharmaceuticals: Major | 26 |
Public Company | Pharmaceuticals: Major | 15 | |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
Public Company | Biotechnology | 10 | |
Mutual Fd-Closed End | Investment Trusts/Mutual Funds | 8 | |
Vtesse, Inc.
Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD.
6
| Subsidiary | Biotechnology | 6 |
Caraway Therapeutics, Inc.
Caraway Therapeutics, Inc. BiotechnologyHealth Technology Caraway Therapeutics, Inc. provides heathcare services. The company was founded by Timothy Harris, Wade Harper ,Ivan Dikic ,Tony Hyman and is headquartered in Cambridge, MA.
3
| Subsidiary | Biotechnology | 3 |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.
3
| Non-Profit Organization | Hospital/Nursing Management | 3 |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018.
2
| Non-Profit Organization | Pharmaceuticals: Major | 2 |
Wyeth-Ayerst Research
2
| Subsidiary | 2 | |
Exonics Therapeutics, Inc.
Exonics Therapeutics, Inc. BiotechnologyHealth Technology Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA.
1
| Subsidiary | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Cristina Csimma via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Leading Biosciences, Inc. provides healthcare services. It offers therapy for severe sepsis, septic shock, and multi-organ failure. The company was founded by John Rodenrys and is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Founder Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Human Resources Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Doctorate Degree | |
Boston University | College/University | Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree Masters Business Admin | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
University of Pennsylvania | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
Georgetown University | College/University | Graduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Founder Director/Board Member Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Graduate Degree Masters Business Admin | |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | President General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer President Corporate Officer/Principal Corporate Officer/Principal | |
Yale University | College/University | Graduate Degree Doctorate Degree Masters Business Admin | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
CATALENT, INC. | Pharmaceuticals: Major | Chief Administrative Officer Chief Executive Officer Director of Finance/CFO | |
Villanova University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Comptroller/Controller/Auditor | |
University of Illinois | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
McGill University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Aceragen, Inc. (North Carolina)
Aceragen, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Aceragen, Inc., Aceragen, Inc. is a biopharmaceutical company that develops therapeutics for orphan diseases. The company is based in Durham, NC. The company was founded in 2021 by John Clayton Taylor. Aceragen, Inc. (North Carolina) was acquired by Idera Pharmaceuticals, Inc. on September 28, 2022. | Pharmaceuticals: Major | Director/Board Member Founder Chief Operating Officer | |
Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree Masters Business Admin Doctorate Degree | |
ARIAD PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
University of Michigan | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree | |
TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
TETRALOGIC PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Catalent France Beinheim SA
Catalent France Beinheim SA Pharmaceuticals: MajorHealth Technology Catalent France Beinheim SA is engaged in softgel development and manufacturing operations. It offers formulation development and manufacturing services for controlled substances, highly potent compounds, and hormones. The firm’s technologies include optiform® solution suite, optigel™ bio, and rp scherer softgel technology. The company was founded on May 3, 1965 and is headquartered in Beinheim, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Burrill LLC
Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
DYAX CORP. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
The University of Edinburgh | College/University | Director/Board Member Doctorate Degree | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Consultant / Advisor | |
REVO BIOLOGICS INC | Biotechnology | Director/Board Member Chief Executive Officer | |
Cydan LLC
Cydan LLC Medical DistributorsDistribution Services Cydan LLC operates as an orphan drug accelerator that identifies and de-risks programs. The firm's model evaluates programs for treating rare diseases with unmet medical need and is aimed at creating new companies to develop those therapies. The company was founded by James G. McArthur in 2013 and is headquartered in Cambridge, MA. | Medical Distributors | Founder Director/Board Member | |
PIERIS PHARMACEUTICALS, INC. | Biotechnology | Chairman Comptroller/Controller/Auditor |
Statistiques
Internationale
Etats-Unis | 45 |
Royaume-Uni | 3 |
Israël | 2 |
Canada | 2 |
Allemagne | 2 |
Sectorielle
Health Technology | 27 |
Consumer Services | 16 |
Commercial Services | 5 |
Finance | 4 |
Health Services | 2 |
Opérationnelle
Director/Board Member | 466 |
Corporate Officer/Principal | 231 |
Independent Dir/Board Member | 144 |
Chief Executive Officer | 95 |
Chairman | 92 |
Relations les plus connectées
Insiders | |
---|---|
Frank Armstrong | 41 |
Stephen Kasnet | 38 |
Julie Cherrington | 32 |
Roel Bulthuis | 29 |
Mary Gray | 27 |
Leonard Patrick Gage | 26 |
James Geraghty | 25 |
Jak Knowles | 24 |
C. Merrifield | 24 |
R. Greer | 23 |
Sara Nayeem | 23 |
Maxine Gowen | 23 |
Edward A. Blechschmidt | 20 |
Robert Kamen | 19 |
Bridget Martell | 18 |
- Bourse
- Insiders
- Cristina Csimma
- Connexions Sociétés